Fochtmann Laura J, Medicus Jennifer, Hong Seung-Hee
Department of Psychiatry, Stony Brook University, Stony Brook, New York (Fochtmann); Division of Policy, Programs, and Partnerships, Department of Practice Management and Delivery Systems Policy, American Psychiatric Association, Washington, D.C. (Medicus, Hong).
Focus (Am Psychiatr Publ). 2020 Oct;18(4):402-423. doi: 10.1176/appi.focus.20200034. Epub 2020 Nov 5.
Schizophrenia is associated with significant health, social, occupational, and economic burdens, including increased mortality. Despite extensive and robust research on the treatment of individuals with schizophrenia, many individuals with the illness do not currently receive evidence-based pharmacological and nonpharmacological treatments. The aims to enhance knowledge and increase the appropriate use of interventions for schizophrenia, thereby improving the quality of care and treatment outcomes. To this end, this evidence-based Performance in Practice tool can facilitate the implementation of a systematic approach to practice improvement for the care of individuals with schizophrenia. This practice assessment activity can also be used in partial fulfillment of Continuing Medical Education and Maintenance of Certification, part IV, requirements, which can also satisfy requirements for the Centers for Medicare & Medicaid Services Merit-based Incentive Payment System program.
精神分裂症与重大的健康、社会、职业和经济负担相关，包括死亡率增加。尽管对精神分裂症患者的治疗进行了广泛而深入的研究，但目前许多患者并未接受基于证据的药物和非药物治疗。其目的是增进知识并增加对精神分裂症干预措施的合理使用，从而改善护理质量和治疗效果。为此，这一基于证据的“实践中的表现”工具可促进为精神分裂症患者护理实施系统性的实践改进方法。这种实践评估活动也可部分满足继续医学教育和认证维持第四部分的要求，同时还能满足医疗保险和医疗补助服务中心基于绩效的激励支付系统计划的要求。
